参考文献/References:
[1] Zhang M,Shi Y,Zhou B,et al. Prevalence,awareness,treatment,and control of hypertension in China,2004-18:findings from six rounds of a national survey[J]. BMJ,2023,380:e071952.
[2] Wang Z,Chen Z,Zhang L,et al. Status of hypertension in China:results from the China Hypertension Survey,2012-2015[J]. Circulation,2018,137(22):2344-2356.
[3] Yin R,Yin L,Li L,et al. Hypertension in China:burdens,guidelines and policy responses:a state-of-the-art review[J]. J Hum Hypertens,2022,36(2):126-134.
[4] Lewington S,Lacey B,Clarke R,et al. The burden of hypertension and associated risk for cardiovascular mortality in China[J]. JAMA Intern Med ,2016,176(4):524-532.
[5] Burnier M. Drug adherence in hypertension[J]. Pharmacol Res,2017,125(Pt B):142-149.
[6] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版) [J]. 中国心血管杂志,2019,24(1):24-56.
[7] Mancia G,Kreutz R,Brunstr?m M,et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension:Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens,2023,41(12):1874-2071.
[8] Bo Y,Kwok KO,Chung VCH,et al. Short-term reproducibility of ambulatory blood pressure measurements:a systematic review and meta-analysis of 35 observational studies[J]. J Hypertens,2020,38(11):2095-2109.
[9] Kang YY,Li Y,Huang QF,et al. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension[J]. J Hypertens,2015,33(8):1580-1587.
[10] Al-Arkee S,Mason J,Lane DA,et al. Mobile apps to improve medication adherence in cardiovascular disease:systematic review and meta-analysis[J]. J Med Internet Res,2021,23(5):e24190.
[11] Mcmanus RJ,Little P,Stuart B,et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension :randomised controlled trial[J]. BMJ,2021,372:m4858.
[12] Lu X,Yang H,Xia X,et al. Interactive mobile health intervention and blood pressure management in adults[J]. Hypertension,2019,74(3):697-704.
[13] Li R,Liang N,Bu F,et al. The effectiveness of self-management of hypertension in adults using mobile health:systematic review and meta-analysis[J]. JMIR Mhealth Uhealth,2020,8(3):e17776.
[14] Mancia G,Kreutz R,Brunstr?m M,et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension:Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)[J]. J Hypertens,2023,41(12):1874-2071.
[15] 王继光. 家庭血压监测中国专家共识[J]. 中国医学前沿杂志(电子版),2012,4(4):43-47.
[16] 陈歆,李燕,刘靖等. 高血压患者高质量血压管理中国专家建议[J/OL]. 中华高血压杂志:1-8[2024-01-14]. http://kns.cnki.net/kcms/detail/11.5540.R.20231212.1333.002.html.
[17] Stevens SL,Wood S,Koshiaris C,et al. Blood pressure variability and cardiovascular disease:systematic review and meta-analysis[J]. BMJ,2016,354:i4098.
[18] Sheikh AB,Sobotka PA,Garg I,et al. Blood pressure variability in clinical practice:past,present and the future[J]. J Am Heart Assoc,2023,12(9):e029297.
[19] Schutte AE,Kollias A,Stergiou GS. Blood pressure and its variability:classic and novel measurement techniques[J]. Nat Rev Cardiol,2022,19(10):643-654.
[20] Buckley LF,Baker WL,van Tassell BW,et al. Systolic blood pressure time in target range and major adverse kidney and cardiovascular events[J]. Hypertension,2023,80(2):305-313.
[21] Huang X,Deng S,Xie W,et al. Time in target range of systolic blood pressure and cognitive outcomes in patients with hypertension[J]. J Am Geriatr Soc,2024,72(2):423-432.
[22] Lin Z,Xiao Z,Chen W,et al. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly:a Chinese veteran cohort study[J]. Eur J Prev Cardiol,2023,30(10):969-977.